MATURE B-CELL MALIGNANCIES
Clinical trials for MATURE B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for MATURE B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer pill enters first human safety tests
Disease control OngoingThis is the first study in people testing BGB-11417, an experimental oral pill designed to block a protein that helps cancer cells survive. The main goals are to find a safe dose and check for side effects in 64 adults with certain relapsed or hard-to-treat B-cell blood cancers, …
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 04, 2026 07:52 UTC
-
New cancer drug enters first human trials for Tough-to-Treat blood cancers
Disease control OngoingThis is an early-stage study to test the safety and find the best dose of a new oral drug called BGB-11417 for adults with several types of advanced B-cell blood cancers that have come back or stopped responding to prior treatments. The study will test the drug by itself and in c…
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC